Source: BIOSPACE

NeXeption: <b>NeXeption</b> Forms New Company <b>Velicept Therapeutics</b>; Intends To Merge With AltheRx To Advance Solabegron For The Treatment Of Overactive Bladder

-James Walker Named Velicept President and Chief Executive Officer-MALVERN, Pa.--(www.businesswire.com/">BUSINESS WIRE)--NeXeption, a biopharmaceutical management company that brings together...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more